Sign up today to learn more about HeartFlow stock

EquityZen is a marketplace for shares of proven pre IPO tech companies

HeartFlow Stock

Medical Technology Company



Notable Investors

Baillie Gifford


Redwood City CA, US

Total Funding


About HeartFlow Stock

HeartFlow is a medical technology company that provides non-invasive coronary artery disease detection services. The company's main product is HeartFlow FFRCT Analysis, which aims to help a physician evaluate whether a patient has significant coronary artery disease. HeartFlow FFRCT Analysis uses a CT scan that is ordered by a physician to generated a 3D model of the patient's coronary arteries. The analysis aims to calculate the amount of blockage in the arteries and the limited blood flow.  The HeartFlow FFRCT Analysis is commercially available in the United States, Canada, Europe and Japan. 

The company additionally offers HeartFlow Planner which allows physicians to model treatment strategies for coronary artery disease.

The company is currently operating with business as usual, albeit with smaller, isolated teams. HeartFlow is allowing for hospitals to divert resources toward COVID-19 by letting algorithms replace invasive procedures like angiograms. 

Christopher K. Zarins and Charles Anthony Taylor founded Cardiovascular Simulation in 2007 that became HeartFlow in May 2009. The company is headquartered in Redwood City, California. For more information, visit


Funding History

July 2009$2.0M
August 2010$6.9M
August 2010$10.1M
December 2011$105M
January 2015$111M
November 2017$340M


Chief Executive Officer

John Stevens

Chief Technology Officer

Charles Anthony Taylor


Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from HeartFlow or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 250K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: